Arrhythmias in Patients with Congenital Heart Disease: An Ongoing Morbidity

Area of Science:

• Cardiology
• Electrophysiology
• Congenital Heart Disease

Background:

• The aging population of congenital heart disease (CHD) patients presents an increasing challenge with a rising burden of arrhythmias.
• Atrial arrhythmias, particularly intra-atrial reentrant tachycardia and atrial fibrillation, are the most frequent cardiac rhythm disturbances in this cohort.

Purpose of the Study:

• To review current knowledge on arrhythmia management strategies in adult patients with CHD.
• To discuss future directions and unresolved questions in the care of CHD patients experiencing arrhythmias.

Main Methods:

• Comprehensive literature review of current guidelines and research on arrhythmias in CHD.
• Analysis of pharmacotherapy, ablation, and device therapy for atrial and ventricular arrhythmias and heart block.
• Discussion of management of comorbidities like obesity in the context of CHD arrhythmias.

Main Results:

• Atrial arrhythmias are highly prevalent, with management strategies including pharmacotherapy and ablation.
• Ventricular tachycardias occur, but primary prevention guidelines using implantable cardioverter defibrillators are limited, except in specific conditions like tetralogy of Fallot.
• Atrioventricular blockages are also observed due to CHD anatomy or surgical interventions.

Conclusions:

• Effective management of arrhythmias in aging CHD patients requires a multifaceted approach addressing comorbidities, pharmacotherapy, and interventional procedures.
• Further research is needed to establish clear guidelines for device therapy, particularly implantable cardioverter defibrillators, for primary prevention of ventricular arrhythmias in most CHD populations.
• Understanding and addressing the evolving arrhythmia landscape in CHD is crucial for improving long-term patient outcomes.